For decades, pralidoxime has been the go-to drug when someone shows up in an ER after organophosphorus exposure. It reactivates acetylcholinesterase—the enzyme that nerve agents and certain pesticides shut down. Combined with atropine and diazepam, it’s saved plenty of lives. But here’s the uncomfortable truth: people who survive the initial poisoning often don’t recover fully. They deal with cognitive problems, mood disorders, neurological symptoms that linger for years. A study published in March 2026 in Cell Death & Differentiation finally explains why—and points toward a solution that doesn’t replace pralidoxime but might finally address what it misses. The Problem Nobody Talked About When you get hit with a nerve agent…